ITB vs XBI
iShares US Home Construction ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.38% for ITB.
- • ITB pays a higher dividend yield (0.62%).
Side-by-side metrics
| Metric | ITB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.38% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.62% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $2.60B | $10.73B |
YTD return | -0.05% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.48 | 1.10 |
P/E ratio | 15.93 | — |
Last price | $97.50 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
ITB top holdings
| DHI | D.R. Horton Inc | 15.77% |
| PHM | PulteGroup Inc | 9.60% |
| LEN | Lennar Corp Class A | 7.15% |
| NVR | NVR Inc | 6.76% |
| TOL | Toll Brothers Inc | 5.05% |
| SHW | Sherwin-Williams Co | 4.55% |
| HD | The Home Depot Inc | 4.44% |
| LOW | Lowe's Companies Inc | 4.10% |
| LII | Lennox International Inc | 3.35% |
| MAS | Masco Corp | 3.03% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ITB
ITB (iShares US Home Construction ETF) is US homebuilding and construction companies. Managed by iShares, the fund carries $2.6B in assets under management, an expense ratio of 0.38%, a dividend yield of 0.62%. Its largest holding is D.R. Horton Inc (DHI), which represents 15.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.